Xtant Medical Holdings, Inc.
XTNT
$0.615
-$0.005-0.81%
AMEX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 35.41M | 32.90M | 31.51M | 27.94M | 29.94M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 35.41M | 32.90M | 31.51M | 27.94M | 29.94M |
| Cost of Revenue | 11.13M | 12.66M | 15.49M | 11.63M | 11.36M |
| Gross Profit | 24.28M | 20.24M | 16.02M | 16.31M | 18.58M |
| SG&A Expenses | 19.09M | 18.74M | 17.38M | 19.38M | 20.89M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 30.79M | 31.84M | 33.40M | 31.71M | 32.89M |
| Operating Income | 4.62M | 1.06M | -1.88M | -3.78M | -2.95M |
| Income Before Tax | 3.81M | 33.00K | -3.14M | -4.96M | -3.83M |
| Income Tax Expenses | 255.00K | -25.00K | 21.00K | 62.00K | 36.00K |
| Earnings from Continuing Operations | 3.55M | 58.00K | -3.17M | -5.02M | -3.86M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 3.55M | 58.00K | -3.17M | -5.02M | -3.86M |
| EBIT | 4.62M | 1.06M | -1.88M | -3.78M | -2.95M |
| EBITDA | 5.79M | 2.14M | -734.00K | -2.70M | -1.95M |
| EPS Basic | 0.03 | 0.00 | -0.02 | -0.04 | -0.03 |
| Normalized Basic EPS | 0.02 | 0.00 | -0.01 | -0.02 | -0.02 |
| EPS Diluted | 0.02 | 0.00 | -0.02 | -0.04 | -0.03 |
| Normalized Diluted EPS | 0.02 | 0.00 | -0.01 | -0.02 | -0.02 |
| Average Basic Shares Outstanding | 139.31M | 139.07M | 158.25M | 135.10M | 130.27M |
| Average Diluted Shares Outstanding | 148.57M | 143.34M | 158.25M | 135.10M | 130.27M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |